Amgen Inc.
VEGFR-FC FUSION PROTEIN FORMULATIONS
Last updated:
Abstract:
VEGFR-Fc fusion protein formulations and methods of making using such formulations are provided herein. In one embodiment, the formulation is an ophthalmic formulation, such as for intravitreal administration. In some embodiments, the VEG-FR-Fc fusion protein is aflibercept.
Status:
Application
Type:
Utility
Filling date:
17 Sep 2018
Issue date:
13 Aug 2020